Application of ginsenoside Rg6 in preparation of anti-cis-platinum drug-resistant ovarian cancer drug

The invention discloses a novel application of ginsenoside Rg6, and particularly discovers that the ginsenoside Rg6 has a unique effect in the aspect of inhibiting the activity of cis-platinum drug-resistant ovarian cancer cells and can reverse the platinum resistance of the ovarian cancer cells, so that the ginsenoside Rg6 can be used for preparing a drug for resisting the cis-platinum drug-resistant ovarian cancer alone or in combination with cis-platinum. And a new medication strategy is provided for the treatment of the cis-platinum drug-resistant ovarian cancer. 本发明公开一种人参皂苷Rg6的新用途，具体是发现了人参皂苷Rg6在抑制顺铂耐药型卵巢癌细胞活力方面具有独特作用，可逆转卵巢癌细胞的铂耐药，使得人参皂苷Rg6可单独或与顺铂联合用于制备抗顺铂耐药型卵巢癌的药物，为顺铂耐药型卵巢癌的治疗提供新的用药策略。